Prev：Intranasal delivery of hMSC-derived supernatant for treatment of ischemic stroke by inhibiting the pro-inflammatory polarization of neutrophils.(KTD101-7.3)
Next：Intravitreal delivery of NMO-IgG causes primary retinal damage in the absence of optic nerve injury.(KTD3001-10.1)
